Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2017

Open Access 01-12-2017 | Research article

Hyperbaric oxygen treatment of spinal cord injury in rat model

Authors: Yongming Sun, Dong Liu, Qingpeng Wang, Peng Su, Qifeng Tang

Published in: BMC Neurology | Issue 1/2017

Login to get access

Abstract

Background

The purpose of this study was to investigate the therapeutic effects and mechanisms of hyperbaric oxygen (HBO) treatment on rats following spinal cord injury (SCI).

Methods

A total of 45 Sprague-Dawley (SD) rats were randomly divided into three groups. Sham-SCI group was surgically exposed but not subjected to the SCI procedure. SCI-control group was administered SCI and treated with regular air. SCI-HBO group was administered SCI and HBO treatment. Neuromotor functions were examined using the Basso, Beattie, and Bresnahan (BBB) locomotor rating scale and the inclined plane assessment at before SCI (baseline) and after SCI. Superoxide dismutase (SOD) activities and malondialdehyde (MDA) levels were measured.

Results

Starting from Day 1 after SCI but except Day 2, the SCI-HBO group has significantly higher BBB scores than the SCI-control group. After SCI, the maximum inclination angles at which rats could maintain were significantly lower in both SCI groups. But the maximum angles were significantly bigger for the rats in the SCI-HBO group than those on the SCI-control group at 5, 10 and 20 days after SCI. SOD activities in SCI-HBO rats were significantly higher and MDA levels were significantly lower than in SCI-control rats, at two and five days after SCI. There was also less cystic degeneration of spinal cord in SCI-HBO rats, compared to SCI-control rats.

Conclusions

These results suggest that HBO treatment has a therapeutic value in treating SCI. Increased oxygen free radical scavenging and reduced lipid oxidation may be one of the mechanisms.
Literature
1.
Hall ED. Lipid antioxidants in actual central nervous system injury. Ann Emerg Med. 1993;22:1022–7.CrossRefPubMed
2.
Hall ED. Inhibition of lipid peroxidation in CNS trauma. J Neurotrauma. 1991;8:S31–40.PubMed
3.
Dayan K, Keser A, Konyalioglu S, et al. The effect of hyperbaric oxygen on neuroregeneration following acute thoracic spinal cord injury. Life Sci. 2012;90:360–4.CrossRefPubMed
4.
Geng C-K, Cao H-H, Ying X, et al. The effects of hyperbaric oxygen on macrophage polarization after rat spinal cord injury. Brain res. 2015;1606:68–76.CrossRefPubMed
5.
Thompson CD, Zurko JC, Hanna BF, et al. The Therapeutic Role of Interleukin-10 after Spinal Cord Injury. J Neurotrauma. 2013;30:1311–24.CrossRefPubMed
6.
Yang Y, Piao Y. Establishmentand evaluationof a SCImodel. Chin J Traumatol. 2002;18:187–90.
7.
Xia L, Sun Y, Sun S, Li J, Niu Y. The effect of PPAR-β on spinal cord and hind limb motor function in rats with spinal cord injury. Zhejiang Clinical Med. 2014;11:1717–9.
8.
Fehlings MG, Tator CH. The relationship among the severity of spinal cord injury, residual neurological function, axon counts and counts of retrogradely labelled neurons after experimental spinal cord injury. ExpNeurol. 1995;134:220–8.
9.
Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. ExpNeurol. 1996;139:244–56.
10.
New P. Inappropriate suggestion of benefit from hyperbaric oxygen for spinal cord injury. Spinal Cord. 2008;46:824–30.CrossRefPubMed
11.
Yin D, Zhou C, Ku S. Et a1. Inhibition of apoptosis by hyperbaric oxygen in rat cerebral ischemic model. Cereb Blood Flow Metab. 2003;23:855–64.CrossRef
12.
Lu P, Feng H, Wang X, et al. Effect ofhyperbaricoxygen preconditioningon neuron apoptosisafter acutespinal cord injury. Chin J Minim Invasive Neurosurg. 2008;13:173–5.
13.
Yaman O, Yaman B, Aydın F, et al. Hyperbaric oxygen treatment in the experimental spinal cord injury model. Spine J. 2014;14:2184–94.CrossRefPubMed
14.
Liu X, Zhou Y, Wang Z, et al. Effect of VEGF and CX43 on the promotion of neurological recovery by hyperbaric oxygen treatment in spinal cord-injured rats. Spine J. 2014;14(1):119–27.CrossRefPubMed
15.
Sun LM. Marti, Hugo H, et a1.Hyperbaric oxygen reduces tissue hypoxia and hypoxia-inducible factor-1 expression in focal cerebral ischemia. Stroke. 2008;39:1000–6.CrossRefPubMed
16.
Yu YM, Yukihiro M, Makoto Y, et al. Effects of hyperbaric oxygen on GDNF expression and apoptosis in spinal cord injury. Neuro report. 2004;15:2369–71.
17.
Fang J, Hou T, Fang Y, et al. Effect of hyperbaric oxygen on excitatory amino acids in rat spinal cord injury. PLA Journal of Medicine. 2002;27(1):1014–9.
18.
Hall ED, Braughler JM. Role of lipid peroxidation in post traumatic spinal cord degeneration:a review in CNS trauma. Cent Nerv Syst Trauma. 1986;3:281–93.CrossRefPubMed
19.
Sun Y, Liu D, Su P, Lin F, Tang Q. Changes in autophagy in rats after spinal cord injury and the effect of hyperbaric oxygen on autophagy. Neurosci Lett. 2016 3;618:139–145.
Metadata
Title
Hyperbaric oxygen treatment of spinal cord injury in rat model
Authors
Yongming Sun
Dong Liu
Qingpeng Wang
Peng Su
Qifeng Tang
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2017
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-017-0909-z

Other articles of this Issue 1/2017

BMC Neurology 1/2017 Go to the issue

Research article

Predictors of post-stroke body temperature elevation

Case report

Early Onset Parkinson’s Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report

Research article

Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study

Research article

The relationship between lower limb muscle volume and body mass in ambulant individuals with bilateral cerebral palsy

Research article

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis – a randomized controlled trial

Research article

Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain